Key Takeaways
What Over-the-Counter Medicine Is Good for Anxiety? The Short Answer
For anyone asking what over-the-counter medicine is good for anxiety, the regulatory answer is that none is approved to treat it in the U.S. A 1979 FDA rule, still in the federal code in 2026, states that "there are no ingredients that can be generally recognized as safe and effective for use as OTC daytime sedatives"[1].
That rule covers label claims such as "occasional simple nervous tension," "calming down and relaxing" and "helps you relax," and it treats any OTC product promoted for those uses as a new drug that needs FDA approval[1]. Anxiety disorders, including generalized anxiety disorder, are treated with psychotherapy, prescription medication or both[7].
What pharmacy shelves do carry falls into three groups: sedating antihistamines labeled for allergies or sleep, dietary supplements that FDA does not approve before sale[8], and CBD products that FDA says are excluded from the supplement definition[9]. The sections below report what the evidence shows for each and where it is thin.
OTC daytime sedative
FDA's regulatory term for a nonprescription product marketed to calm or relax a person during the day, with claims such as "nervous irritability," "restlessness" or "a relaxed feeling." Antihistamines, bromides and scopolamine compounds were once sold this way; any such product introduced into interstate commerce after December 24, 1979, without complying with the rule is subject to regulatory action[1].
Related Terms
Source: 21 CFR 310.519, U.S. Food and Drug Administration
Can Benadryl or Other OTC Antihistamines Help Anxiety?
Diphenhydramine, the antihistamine in Benadryl, Nytol, Sominex and Unisom, is labeled to treat allergy and cold symptoms, insomnia in adults and motion sickness[2]. Anxiety is not among its listed uses, and drowsiness, dizziness, dry mouth and muscle weakness are among its side effects[2].
It is also an ingredient in combination products such as Advil PM, Excedrin PM and several nighttime cold formulas[2]. Its role as an OTC sleep aid is covered in our review of sleeping pills.
MedlinePlus states that diphenhydramine generally should not be used in adults 65 and older, except to manage serious allergic reactions, because it is not as safe or effective as other medications[2]. Long-term exposure is a separate question: in a Seattle cohort of 3,434 adults aged 65 and older, the highest cumulative use of strong anticholinergic drugs, whose most common classes included first-generation antihistamines, was associated with a higher dementia risk (adjusted hazard ratio 1.54)[10].
That study measured an association, not a cause, and the top exposure group had filled more than 1,095 standardized daily doses over 10 years[10]. At the lowest exposure level, 1 to 90 standardized daily doses, the hazard ratio was 0.92, not statistically different from no use[10].
Hydroxyzine has anxiety data, but it requires a prescription
Hydroxyzine (Vistaril) is an antihistamine used to relieve anxiety and tension, and MedlinePlus describes it as a prescription medication[11]. A 2010 Cochrane review of 5 studies with 884 participants found hydroxyzine more effective than placebo for generalized anxiety disorder (odds ratio 0.30)[3].
The review rated its included studies at high risk of bias and concluded that, given the stronger evidence for antidepressants, hydroxyzine should not be recommended as a first-line GAD treatment[3]. Hydroxyzine was also associated with more sleepiness than the benzodiazepine and buspirone comparators[3].
OTC ingredients FDA recognizes as safe and effective for daytime calming claims such as nervous tension or stress
FDA treats any nonprescription product promoted for nervous tension, restlessness or relaxation as a new drug requiring approval. Products sold for calm today are mostly dietary supplements, which follow different rules.
"there are no ingredients that can be generally recognized as safe and effective for use as OTC daytime sedatives"
OTC Products Marketed for Calm: Legal Status and Anxiety Evidence
| Product | How it is sold in the U.S. | Anxiety evidence | Main safety flag |
|---|---|---|---|
| Diphenhydramine (Benadryl) | OTC drug for allergy, cold, sleep, motion sickness | Not labeled for anxiety | Drowsiness, generally avoided at 65+ |
| Hydroxyzine (Vistaril) | Prescription only | Beat placebo for GAD in 5 small trials | Sleepiness, not first-line |
| Lavender oil, oral (Silexan) | Dietary supplement | Effective in pooled trials | Headache, constipation, adds to sedatives |
| Chamomile extract | Dietary supplement | Preliminary GAD trials | Allergy, warfarin and cyclosporine interactions |
| Kava | Dietary supplement | Short-term benefit in GAD | Rare serious liver injury |
| Valerian | Dietary supplement | Not enough evidence | Withdrawal after chronic use |
| Melatonin | Dietary supplement | Pre-surgery anxiety only | Label content unreliable |
| CBD products | Excluded from supplement definition | No FDA-approved anxiety use | Not FDA-evaluated |
Regulatory status and evidence summaries for products sold without a prescription in the U.S., drawn from FDA, MedlinePlus, Cochrane and NCCIH sources published 2010 to 2026[2][11][3][9].
1Supplement evidence and safety summaries are from NCCIH's 2020 Clinical Digest on anxiety and its 2025 kava and valerian fact sheets[4][12][13].
2Melatonin label accuracy is from a 2023 analysis of 25 gummy products sold in the U.S.[5]
Sources
- •FDA, 2024-2026
- •MedlinePlus, 2026
- •Cochrane, 2010
- •NCCIH, 2020-2025
- •JAMA, 2023
Which OTC Supplements Have Evidence for Anxiety?
NCCIH, the NIH center that reviews complementary health products, describes much of the supplement research on anxiety as preliminary or of poor methodological quality[4].
Lavender oil
A 2019 meta-analysis summarized by NCCIH pooled 37 randomized trials with 3,964 participants and found oral lavender essential oil effective for anxiety, while evidence for inhaled lavender was less consistent[4]. A 2017 meta-analysis of 5 studies with 1,165 participants found the lavender oil preparation Silexan significantly better than placebo[4].
Chamomile
Chamomile extract reduced symptoms over 8 weeks in a 2016 study of 179 people with moderate to severe generalized anxiety disorder, and showed modest effects in a 2009 placebo-controlled trial of 57 patients[4]. NCCIH calls these findings preliminary and not conclusive[4].
Kava
In a 2013 randomized trial of 75 people with GAD, standardized kava extract was a moderately effective short-term option[4]. NCCIH's 2025 fact sheet adds that kava products have been linked to rare cases of liver injury, some serious or fatal[12].
A 2018 systematic review summarized by NCCIH found that kava may produce short-term improvement but is not a replacement for prolonged anti-anxiety treatment, and that liver toxicity is especially possible when it is taken longer than 8 weeks[4].
Valerian and melatonin
NCCIH's 2025 review finds not enough evidence to draw any conclusion about valerian for anxiety, and it reports that the American Academy of Sleep Medicine recommended against valerian for chronic insomnia in 2017[13]. Melatonin's anxiety evidence comes from surgery: a 2015 Cochrane review of 12 studies with 774 participants found it reduced preoperative anxiety compared with placebo[4]. NCCIH adds that melatonin supplements appear safe for short-term use, with less known about long-term safety[4].
Magnesium, L-theanine, ashwagandha and omega-3 fatty acids are reviewed in our guides to supplements for anxiety, magnesium for anxiety and ashwagandha for anxiety.
Why Over the Counter Does Not Mean FDA Approved
Supplements reach shelves under different rules than drugs. Under the Dietary Supplement Health and Education Act (DSHEA), FDA does not have the authority to approve dietary supplements before they are marketed, and it generally does not approve their claims or labels[8].
A product sold as a supplement that claims to treat, prevent or cure a specific disease meets the legal definition of a drug[8]. Supplement labels with structure or function claims must carry a disclaimer that the product is not intended to "diagnose, treat, cure, or prevent any disease"[8].
Label accuracy is a documented problem. When researchers tested 25 melatonin gummy products sold in the U.S., actual melatonin ranged from 74% to 347% of the labeled amount, and one product contained no detectable melatonin but 31.3 mg of CBD[5].
CBD sits outside both categories. FDA has concluded that CBD products are excluded from the dietary supplement definition, and the only FDA-approved CBD drug, Epidiolex, is approved for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex[9]. Cannabis and anxiety research is covered in is weed good for anxiety.
What Side Effects and Interactions Are Documented?
A study of a nationally representative sample of U.S. emergency departments estimated 23,005 visits a year from 2004 through 2013 for adverse events related to dietary supplements, with an estimated 2,154 hospitalizations a year[6].
Weight-loss products (25.5% of visits) and energy products (10.0%) were commonly implicated, and young adults aged 20 to 34 accounted for 28.0% of visits[6].
St. John's wort can weaken many medicines, including birth control pills, warfarin, some antidepressants, some seizure and heart drugs, and certain statins[14]. Taken with certain antidepressants or other drugs that affect serotonin, it may lead to serious serotonin-related side effects[14].
Chamomile has been linked to allergic reactions, including rare anaphylaxis, particularly in people allergic to ragweed, chrysanthemums, marigolds or daisies, and to interactions with cyclosporine and warfarin[4]. Oral lavender may cause headache, appetite changes and constipation, and may increase drowsiness when combined with sedatives[4].
Kava has been associated with cases of dystonia and may interact with several drugs, including Parkinson's disease medications[4]. Valerian appears generally safe for short-term use by most adults, but stopping it abruptly after chronic use may cause withdrawal symptoms, including anxiety, irritability and insomnia[13].
How Do OTC Options Compare With Prescription Anxiety Treatment?
NIMH lists two groups of prescription medication for GAD: antidepressants such as SSRIs and SNRIs, and anti-anxiety medications such as benzodiazepines and buspirone[7]. SSRIs and SNRIs may take several weeks to start working, and buspirone needs 3 to 4 weeks to be fully effective[7].
Benzodiazepines can rapidly decrease anxiety, but some people build up tolerance or become dependent, so they may be prescribed only for brief periods[7]. Psychotherapy, alone or combined with medication, is the other standard treatment[7].
Drug classes and trial results are compared in our guides to anxiety medication, SSRIs for anxiety and the best medicine for anxiety. Prevalence figures are on the anxiety statistics page.
Frequently Asked Questions
Sources & References
- U.S. Food and Drug Administration. 21 CFR 310.519: Drug products marketed as over-the-counter (OTC) daytime sedatives. Electronic Code of Federal Regulations. Published 1979. Accessed October 2026. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-310/subpart-E/section-310.519 [Link]
- National Library of Medicine. Diphenhydramine: MedlinePlus Drug Information. MedlinePlus. Published 2026. Accessed October 2026. https://medlineplus.gov/druginfo/meds/a682539.html [Link]
- Guaiana G, Barbui C, Cipriani A. Hydroxyzine for generalised anxiety disorder. Cochrane Database of Systematic Reviews. Published 2010. Accessed October 2026. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006815.pub2/full [Link]
- National Center for Complementary and Integrative Health. Anxiety and Complementary Health Approaches: What the Science Says. NCCIH Clinical Digest. Published 2020. Accessed October 2026. https://www.nccih.nih.gov/health/providers/digest/anxiety-and-complementary-health-approaches-science [Link]
- Cohen PA, Avula B, Wang YH, Katragunta K, Khan I. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US. JAMA. Published 2023. Accessed October 2026. https://jamanetwork.com/journals/jama/fullarticle/2804077 [Link]
- Geller AI, Shehab N, Weidle NJ, et al. Emergency Department Visits for Adverse Events Related to Dietary Supplements. New England Journal of Medicine. Published 2015. Accessed October 2026. https://www.nejm.org/doi/full/10.1056/NEJMsa1504267 [Link]
- National Institute of Mental Health. Generalized Anxiety Disorder: What You Need to Know. National Institutes of Health. Published 2025. Accessed October 2026. https://www.nimh.nih.gov/health/publications/generalized-anxiety-disorder-gad [Link]
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. FDA. Published 2026. Accessed October 2026. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements [Link]
- U.S. Food and Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD). FDA. Published 2024. Accessed October 2026. https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd [Link]
- Gray SL, Anderson ML, Dublin S, et al. Cumulative Use of Strong Anticholinergics and Incident Dementia: A Prospective Cohort Study. JAMA Internal Medicine. Published 2015. Accessed October 2026. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2091745 [Link]
- National Library of Medicine. Hydroxyzine: MedlinePlus Drug Information. MedlinePlus. Published 2026. Accessed October 2026. https://medlineplus.gov/druginfo/meds/a682866.html [Link]
- National Center for Complementary and Integrative Health. Kava: Usefulness and Safety. National Institutes of Health. Published 2025. Accessed October 2026. https://www.nccih.nih.gov/health/kava [Link]
- National Center for Complementary and Integrative Health. Valerian: Usefulness and Safety. National Institutes of Health. Published 2025. Accessed October 2026. https://www.nccih.nih.gov/health/valerian [Link]
- National Center for Complementary and Integrative Health. St. John's Wort: Usefulness and Safety. National Institutes of Health. Published 2025. Accessed October 2026. https://www.nccih.nih.gov/health/st-johns-wort [Link]